ArticleMedicine2025
Bioinformatics analysis of glycolysis-related differentially expressed genes (GRDEGs) and their significance in ischemic stroke.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The incidence of ischemic stroke (IS) is escalating rapidly, and glycolysis significantly influences the pathogenesis and prognosis of these patients. However, current methods for assessing this are insufficient. This study aimed to identify molecular biomarkers of glycolysis in patients with IS. We retrieved relevant data from the Gene Expression Omnibus database and identified differentially expressed genes (DEGs). Gene set enrichment analysis was conducted on all genes within the integrated Gene Expression Omnibus dataset. Glycolysis-related differentially expressed genes (GRDEGs) were subjected to gene ontology and pathway analysis (Kyoto Encyclopedia of Genes and Genomes) to determine the functions of DEGs. The protein-protein interaction network of GRDEGs was established using the STRING database. The miRNAs of glycolysis-associated hub genes were acquired from the StarBase and miRDB databases, followed by an analysis of the relationship between glycolysis-related core genes and miRNAs. The mRNA-miRNA regulatory network was visualized. Lastly, a cross-comparison of immune-related genes and GRDEGs in IS was conducted to compare immune cell infiltration between the 2 groups. In the IS group, there were 42 up-regulated genes, 73 down-regulated genes, and 27 GRDEGs compared with the control group. These genes are involved in regulating various biological processes and signaling pathways. The protein-protein interaction network identified 7 hub genes related to glycolysis, including C-C motif chemokine receptor 7, ribosomal protein S3, and ribosomal protein SA, which also have immune correlations. Ribosomal protein SA, ribosomal protein S3, eukaryotic translation elongation factor 1 gamma, CD163, arginase 1, C-C motif chemokine receptor 7, and matrix metallopeptidase 9 are the hub genes related to glycolysis in IS. Our research will contribute to the discovery of potential biomarkers and fresh approaches to the clinical management of IS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.